Creon (pancrelipase) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat exocrine pancreatic insufficiency (EPI) in certain infants, children, and ...
ABBOTT PARK, Ill., June 14, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) ...
Prior to this FDA approval, dosing guidance for medications such as CREON was based on patients with cystic fibrosis. Exocrine pancreatic insufficiency (EPI) is the inability to properly digest food ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. CREON MICRO contains the active ingredient Pancreatic Extract. CREON ...
Creon (pancrealipase) is a prescription drug that’s used to treat exocrine pancreatic insufficiency (EPI). Creon comes as a delayed-release oral capsule. It’s usually taken with each meal. Creon is ...